A citation-based method for searching scientific literature

Per Eriksson, Philip Wallin, Christopher Sjöwall. Front Pharmacol 2019
Times Cited: 17







List of co-cited articles
90 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
140
58

N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily,[...]. Arthritis Rheum 2012
185
52

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
David Fernandez, Eduardo Bonilla, Naureen Mirza, Brian Niland, Andras Perl. Arthritis Rheum 2006
197
47


Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Zachary Oaks, Thomas Winans, Tiffany Caza, David Fernandez, Yuxin Liu, Steve K Landas, Katalin Banki, Andras Perl. Arthritis Rheumatol 2016
51
29

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
David R Fernandez, Tiffany Telarico, Eduardo Bonilla, Qing Li, Sanjay Banerjee, Frank A Middleton, Paul E Phillips, Mary K Crow, Stefanie Oess, Werner Muller-Esterl,[...]. J Immunol 2009
144
29



Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Zachary Oaks, Thomas Winans, Nick Huang, Katalin Banki, Andras Perl. Curr Rheumatol Rep 2016
40
23

CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Tomohiro Koga, Christian M Hedrich, Masayuki Mizui, Nobuya Yoshida, Kotaro Otomo, Linda A Lieberman, Thomas Rauen, José C Crispín, George C Tsokos. J Clin Invest 2014
103
23

Normalization of CD4+ T cell metabolism reverses lupus.
Yiming Yin, Seung-Chul Choi, Zhiwei Xu, Daniel J Perry, Howard Seay, Byron P Croker, Eric S Sobel, Todd M Brusko, Laurence Morel. Sci Transl Med 2015
280
23

Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
Desmond Y H Yap, Colin Tang, Gary C W Chan, Lorraine P Y Kwan, Maggie K M Ma, Maggie M Y Mok, Tak Mao Chan. J Rheumatol 2018
21
23

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Christian Lood, Luz P Blanco, Monica M Purmalek, Carmelo Carmona-Rivera, Suk S De Ravin, Carolyne K Smith, Harry L Malech, Jeffrey A Ledbetter, Keith B Elkon, Mariana J Kaplan. Nat Med 2016
530
17

Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience.
Desmond Y H Yap, Maggie K M Ma, Colin So Tang, Tak Mao Chan. Nephrology (Carlton) 2012
29
17

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Zhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, Jianghong Yu, Maha Dawood, Ricardo Garcia, Lisa Francis, Hajra Tily, Adam Bartos, Stephen V Faraone,[...]. J Immunol 2013
75
17

Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Guillaume Canaud, Frank Bienaimé, Fanny Tabarin, Guillaume Bataillon, Danielle Seilhean, Laure-Hélène Noël, Marie-Agnès Dragon-Durey, Renaud Snanoudj, Gérard Friedlander, Lise Halbwachs-Mecarelli,[...]. N Engl J Med 2014
166
17

The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin.
Kostas Stylianou, Ioannis Petrakis, Vasiliki Mavroeidi, Stavros Stratakis, Eleftheria Vardaki, Kostas Perakis, Spyros Stratigis, Andreas Passam, Eva Papadogiorgaki, Kostas Giannakakis,[...]. Nephrol Dial Transplant 2011
55
17


Metformin Suppresses Systemic Autoimmunity in Roquinsan/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3.
Seon-Yeong Lee, Su-Jin Moon, Eun-Kyung Kim, Hyeon-Beom Seo, Eun-Ji Yang, Hye-Jin Son, Jae-Kyung Kim, Jun-Ki Min, Sung-Hwan Park, Mi-La Cho. J Immunol 2017
51
17

Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
Daniel Cejka, Silvia Hayer, Birgit Niederreiter, Wolfgang Sieghart, Thorsten Fuereder, Jochen Zwerina, Georg Schett. Arthritis Rheum 2010
110
17

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
17

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
959
17

Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters.
Wei Li, Ganlin Qu, Seung-Chul Choi, Caleb Cornaby, Anton Titov, Natalie Kanda, Xiangyu Teng, Haiting Wang, Laurence Morel. Front Immunol 2019
29
17

Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
Michihito Kono, Kayaho Maeda, Irina Stocton-Gavanescu, Wenliang Pan, Masataka Umeda, Eri Katsuyama, Catalina Burbano, Seo Yeon K Orite, Milena Vukelic, Maria G Tsokos,[...]. JCI Insight 2019
24
17

Immunometabolism in systemic lupus erythematosus.
Laurence Morel. Nat Rev Rheumatol 2017
92
17

Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Michihito Kono, Nobuya Yoshida, Kayaho Maeda, Abel Suárez-Fueyo, Vasileios C Kyttaris, George C Tsokos. Arthritis Rheumatol 2019
18
17

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Tiffany N Caza, David R Fernandez, Gergely Talaber, Zachary Oaks, Mark Haas, Michael P Madaio, Zhi-Wei Lai, Gabriella Miklossy, Ram R Singh, Dmitriy M Chudakov,[...]. Ann Rheum Dis 2014
72
17

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.
Michihito Kono, Nobuya Yoshida, Kayaho Maeda, Nicole E Skinner, Wenliang Pan, Vasileios C Kyttaris, Maria G Tsokos, George C Tsokos. Proc Natl Acad Sci U S A 2018
22
17

Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Sing Leung Lui, Ryan Tsang, Kwok Wah Chan, Florence Zhang, Sidney Tam, Susan Yung, Tak Mao Chan. Nephrol Dial Transplant 2008
55
17



Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Karen L Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P Lambert, Jack J Bleesing, Alix E Seif, Catherine S Manno, James Casper, Stephan A Grupp, David T Teachey. Blood 2016
91
17


Genetic advances in systemic lupus erythematosus: an update.
Lingyan Chen, David L Morris, Timothy J Vyse. Curr Opin Rheumatol 2017
69
11

Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus.
Roberto Lande, Dipyaman Ganguly, Valeria Facchinetti, Loredana Frasca, Curdin Conrad, Josh Gregorio, Stephan Meller, Georgios Chamilos, Rosalie Sebasigari, Valeria Riccieri,[...]. Sci Transl Med 2011
751
11


Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.
Peter Gergely, Craig Grossman, Brian Niland, Ferenc Puskas, Hom Neupane, Fatme Allam, Katalin Banki, Paul E Phillips, Andras Perl. Arthritis Rheum 2002
200
11

Metabolic abnormalities and oxidative stress in lupus.
Yaima L Lightfoot, Luz P Blanco, Mariana J Kaplan. Curr Opin Rheumatol 2017
32
11

Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin.
Andras Perl, Robert Hanczko, Zhi-Wei Lai, Zachary Oaks, Ryan Kelly, Rebecca Borsuk, John M Asara, Paul E Phillips. Metabolomics 2015
61
11

Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Yuan-Yuan Qi, Xu-Jie Zhou, Fa-Juan Cheng, Ping Hou, Ya-Li Ren, Su-Xia Wang, Ming-Hui Zhao, Li Yang, Jennifer Martinez, Hong Zhang. Ann Rheum Dis 2018
25
11

Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation.
Huimin Yan, Hui-Fang Zhou, Ying Hu, Christine T N Pham. J Rheum Dis Treat 2015
43
11

Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
A Ramos-Barrón, C Piñera-Haces, C Gómez-Alamillo, I Santiuste-Torcida, J C Ruiz, L Buelta-Carrillo, R Merino, A L M de Francisco, M Arias. Lupus 2007
38
11




Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells.
Anton A Titov, Henry V Baker, Todd M Brusko, Eric S Sobel, Laurence Morel. J Immunol 2019
13
15


Metabolism as a Target for Modulation in Autoimmune Diseases.
Nick Huang, Andras Perl. Trends Immunol 2018
48
11

Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.
Ricardo J Garcia, Lisa Francis, Maha Dawood, Zhi-Wei Lai, Stephen V Faraone, Andras Perl. Arthritis Rheum 2013
52
11

Rapamycin: one drug, many effects.
Jing Li, Sang Gyun Kim, John Blenis. Cell Metab 2014
463
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.